Edgewise 治療公司
US ˙ NasdaqGS ˙ US28036F1057

簡介

本頁面提供了有關 John R Moore 已知的內部交易歷史的全面分析。內部人士包括公司的高管、董事或重要投資者。一般而言,基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是,他們必須透過Form 4向美國證券交易委員會(SEC)報告所有交易。盡管存在這些限制,學術研究表明,內部人士 - 整體而言 - 在自己公司中的投資表現往往優於市場。

平均交易盈利能力

「平均交易盈利能力」衡量了內部人士在過去三年中所有非計劃性的公開市場購買交易的平均回報率。計算過程包括檢查每筆交易,排除了作為10b5-1交易計劃的一部分的交易。然後,對每筆交易在3、6和12個月的表現進行平均,以生成該筆交易最終的表現指標。最終,將所有交易的表現指標進行平均,計算出內部人士的總體平均表現指標。列表僅包含在過去兩年中進行過至少三筆交易的內部人士。

如果內部人士的交易盈利能力顯示為"N/A",則可能是因為該內部人士在過去三年內沒有進行任何公開市場購買交易,或者他們進行的交易距離現在太近,無法計算出可靠的表現指標。

更新頻率:每日

查看收益最高的的內幕交易者列表。

報告內部持倉的公司

SEC文件顯示John R Moore已報告在以下公司擁有持倉或進行了交易:

證券 職位 最新報告的持倉
US:EWTX / Edgewise Therapeutics, Inc. General Counsel 10,214
US:04269XAA3 / Array BioPharma Inc. Bonds 3.0% 6/1/2020 VP, General Counsel 40,102
US:NVLS / Nivalis Therapeutics, Inc. Director 12,300
如何解讀這些圖表

以下圖表顯示了在John R Moore進行的每筆公開市場非計劃交易後證券的股價表現。非計劃交易是指沒有作為10b5-1交易計劃的一部分而進行的交易。股價表現以累積百分比變化的方式繪製。例如,如果一筆內部人士交易是在2019年1月1日進行的,該圖表將顯示該證券的每日百分比變化直至當前日期。如果在此期間股價從10美元漲至15美元,則股價的累積百分比變化將為50%。從10美元漲至20美元的價格變化將為100%,而從10美元跌至5美元的價格變化將為-50%。

最終,我們將評估內部人士的交易與股價的超額回報(正向或負向)之間的相關性,以判斷內部人士是否在交易中利用內部信息獲利。如果內部人士有這樣的行為,我們預期看到(a)購買後的正回報,或者(b)賣出後的負回報。對於情況(a),購買圖表將顯示一系列向上傾斜的曲線,表示每次購買後都有正回報。對於情況(b),賣出圖表將顯示一系列向下傾斜的曲線,表示每次賣出後都有負回報。

然而,僅憑這一點還不足以得出結論。例如,如果公司的股價在多年內呈現非周期性上升,我們會預期所有購買後的圖表都呈現向上傾斜。同樣地,多年來呈現非周期性下降的股價會導致賣出後的圖表也呈現向下傾斜。這兩種情況的圖表都不能表示內部人士在進行內幕交易。

最有力的指標是在公司股價呈極度循環波動的情況下,「購買」圖表顯示正向信號,而「賣出」圖表顯示負向趨勢。這種情況強烈暗示內部人士可能根據內幕信息精確地計時進行交易,以獲得財務優勢。

EWTX / Edgewise Therapeutics, Inc.內部人士買入 - 短期收益分析

在這一部分,我們分析了在 EWTX / Edgewise Therapeutics, Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報,以及是否值得跟踪。該分析基於每筆交易後一年的情況,結果僅為理論值

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數
Reported
價格
經調整
股數
經調整
價格
成本基礎 達到最高利潤的
天數
達到最高利潤時的
價格
最高
淨利 ($)
最高回報率(%)
當前未知該內部人士及證券組合進行過任何未預先計劃的公開市場交易。

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

EWTX / Edgewise Therapeutics, Inc. Insider Trades
EWTX / Edgewise Therapeutics, Inc.內部人士賣出 - 短期虧損分析

在這一部分,我們分析了在 EWTX / Edgewise Therapeutics, Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式,可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況,

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數
Reported
價格
經調整
股數
經調整
價格
成本基礎 達到最低利潤的
天數
達到最低利潤時的
價格
避免的
最高損失金額($)
避免的
最高損失率($)
2025-08-12 EWTX MOORE JOHN R 2,098 13.3924 2,098 13.3924 28,097 0 13.3900 -5 -0.02
2025-05-02 EWTX MOORE JOHN R 1,930 16.4542 1,930 16.4542 31,757
2024-09-23 EWTX MOORE JOHN R 20,922 27.6295 20,922 27.6295 578,064
2024-09-20 EWTX MOORE JOHN R 50,000 28.3702 50,000 28.3702 1,418,510
2024-05-02 EWTX MOORE JOHN R 1,956 18.9100 1,956 18.9100 36,988
2024-02-09 EWTX MOORE JOHN R 8,029 20.0096 8,029 20.0096 160,657
2024-02-08 EWTX MOORE JOHN R 3,813 20.0065 3,813 20.0065 76,285
2024-02-07 EWTX MOORE JOHN R 17,993 20.0002 17,993 20.0002 359,864
2023-05-02 EWTX MOORE JOHN R 1,897 8.9049 1,897 8.9049 16,893
2022-08-03 EWTX MOORE JOHN R 9,232 9.3069 9,232 9.3069 85,921
2022-07-06 EWTX MOORE JOHN R 1,046 8.5352 1,046 8.5352 8,928
2022-07-05 EWTX MOORE JOHN R 8,186 8.3470 8,186 8.3470 68,329
2022-06-21 EWTX MOORE JOHN R 31,078 7.2944 31,078 7.2944 226,695
2022-06-17 EWTX MOORE JOHN R 22,127 6.6179 22,127 6.6179 146,434
2022-06-16 EWTX MOORE JOHN R 14,722 6.1680 14,722 6.1680 90,805
2022-06-15 EWTX MOORE JOHN R 585 6.1104 585 6.1104 3,575
2022-06-15 EWTX MOORE JOHN R 18,075 6.1104 18,075 6.1104 110,445
2022-06-14 EWTX MOORE JOHN R 3,628 6.0239 3,628 6.0239 21,855
2022-06-13 EWTX MOORE JOHN R 4,093 6.0058 4,093 6.0058 24,582
2022-06-10 EWTX MOORE JOHN R 7,125 6.0519 7,125 6.0519 43,120
2022-06-09 EWTX MOORE JOHN R 7,615 6.4868 7,615 6.4868 49,397
2022-06-08 EWTX MOORE JOHN R 12,566 6.6339 12,566 6.6339 83,362
2022-06-07 EWTX MOORE JOHN R 973 6.6050 973 6.6050 6,427
2022-06-07 EWTX MOORE JOHN R 17,150 6.6050 17,150 6.6050 113,276
2022-06-06 EWTX MOORE JOHN R 13,934 6.0345 13,934 6.0345 84,085
2022-06-03 EWTX MOORE JOHN R 15,230 6.0537 15,230 6.0537 92,198

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

EWTX / Edgewise Therapeutics, Inc. Insider Trades
歷史內部人交易

該表格顯示了由 John R Moore 進行的所有內幕交易的完整列表,這些交易已向美國證券交易委員會(SEC)披露。

呈報日期 交易日期 表格 證券代碼 證券 代碼 10b5-1 股份 剩餘股份 %
變化
每股
股價
交易
金額
剩餘
金額
2025-08-14 2025-08-12 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale -2,098 10,214 -17.04 13.39 -28,097 136,790
2025-08-14 2025-08-12 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise 5,781 12,312 88.52
2025-05-07 2025-05-02 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale -1,930 6,531 -22.81 16.45 -31,757 107,462
2025-05-07 2025-05-01 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise 5,209 8,461 160.18
2024-09-24 2024-09-23 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale -20,922 3,252 -86.55 27.63 -578,064 89,851
2024-09-24 2024-09-23 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise 20,922 24,174 643.36 0.71 14,855 17,164
2024-09-24 2024-09-20 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale -50,000 3,252 -93.89 28.37 -1,418,510 92,260
2024-09-24 2024-09-20 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise 50,000 53,252 1,537.52 0.71 35,500 37,809
2024-05-03 2024-05-02 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale -1,956 3,252 -37.56 18.91 -36,988 61,495
2024-05-03 2024-05-01 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise 5,208 5,208
2024-02-09 2024-02-09 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale -8,029 0 -100.00 20.01 -160,657
2024-02-09 2024-02-09 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise 8,029 8,029 1.93 15,496 15,496
2024-02-09 2024-02-08 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale -3,813 0 -100.00 20.01 -76,285
2024-02-09 2024-02-08 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise 3,813 3,813 1.93 7,359 7,359
2024-02-09 2024-02-07 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale -17,993 0 -100.00 20.00 -359,864
2024-02-09 2024-02-07 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise X 17,993 17,993 1.93 34,726 34,726
2023-12-28 2023-12-27 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale X -8,497 0 -100.00 10.50 -89,218
2023-05-03 2023-05-02 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale -1,897 6,565 -22.42 8.90 -16,893 58,461
2023-05-03 2023-05-01 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise 5,208 8,462 160.05
2022-10-05 2022-10-03 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale X -4,730 3,000 -61.19 9.76 -46,155 29,274
2022-10-05 2022-10-03 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise 4,730 7,730 157.67 1.93 9,129 14,919
2022-09-08 2022-09-06 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale X -2,351 3,000 -43.94 10.99 -25,842 32,976
2022-09-08 2022-09-06 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale X -2,379 5,351 -30.78 10.83 -25,756 57,931
2022-09-08 2022-09-06 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise 4,730 7,730 157.67 1.93 9,129 14,919
2022-08-05 2022-08-03 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale -9,232 3,000 -75.47 9.31 -85,921 27,921
2022-08-05 2022-08-03 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise 4,502 12,232 58.24 0.71 3,196 8,685
2022-08-05 2022-08-03 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise X 4,730 7,730 157.67 1.93 9,129 14,919
2022-07-07 2022-07-06 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale -1,046 3,000 -25.85 8.54 -8,928 25,606
2022-07-07 2022-07-06 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise 1,046 4,046 34.87 1.93 2,019 7,809
2022-07-07 2022-07-05 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale -8,186 3,000 -73.18 8.35 -68,329 25,041
2022-07-07 2022-07-05 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise 4,502 11,186 67.35 0.71 3,196 7,942
2022-07-07 2022-07-05 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise X 3,684 6,684 122.80 1.93 7,110 12,900
2022-06-21 2022-06-21 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale -31,078 3,000 -91.20 7.29 -226,695 21,883
2022-06-21 2022-06-21 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise 17,570 34,078 106.43 1.93 33,910 65,771
2022-06-21 2022-06-21 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise 13,508 16,508 450.27 0.71 9,591 11,721
2022-06-21 2022-06-17 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale -22,127 3,000 -88.06 6.62 -146,434 19,854
2022-06-21 2022-06-17 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise 22,127 25,127 737.57 1.93 42,705 48,495
2022-06-21 2022-06-16 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale -14,722 3,000 -83.07 6.17 -90,805 18,504
2022-06-21 2022-06-16 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise X 14,722 17,722 490.73 1.93 28,413 34,203
2022-06-15 2022-06-15 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale -18,075 3,000 -85.77 6.11 -110,445 18,331
2022-06-15 2022-06-15 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale -585 21,075 -2.70 6.11 -3,575 128,777
2022-06-15 2022-06-15 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise 585 21,660 2.78 1.93 1,129 41,804
2022-06-15 2022-06-15 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise 18,075 21,075 602.50 0.71 12,833 14,963
2022-06-15 2022-06-14 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale -3,628 3,000 -54.74 6.02 -21,855 18,072
2022-06-15 2022-06-14 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise 3,628 6,628 120.93 0.71 2,576 4,706
2022-06-15 2022-06-13 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale -4,093 3,000 -57.70 6.01 -24,582 18,017
2022-06-15 2022-06-13 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise X 4,093 7,093 136.43 0.71 2,906 5,036
2022-06-10 2022-06-10 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale -7,125 3,000 -70.37 6.05 -43,120 18,156
2022-06-10 2022-06-10 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise 7,125 10,125 237.50 0.71 5,059 7,189
2022-06-10 2022-06-09 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale -7,615 3,000 -71.74 6.49 -49,397 19,460
2022-06-10 2022-06-09 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise 7,615 10,615 253.83 0.71 5,407 7,537
2022-06-10 2022-06-08 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale -12,566 3,000 -80.73 6.63 -83,362 19,902
2022-06-10 2022-06-08 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise X 12,566 15,566 418.87 0.71 8,922 11,052
2022-06-07 2022-06-07 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale -17,150 3,000 -85.11 6.60 -113,276 19,815
2022-06-07 2022-06-07 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise 17,150 20,150 571.67 0.71 12,176 14,306
2022-06-07 2022-06-07 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale -973 3,000 -24.49 6.60 -6,427 19,815
2022-06-07 2022-06-07 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise 973 3,973 32.43 1.93 1,878 7,668
2022-06-07 2022-06-06 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale -13,934 3,000 -82.28 6.03 -84,085 18,104
2022-06-07 2022-06-06 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise 13,934 16,934 464.47 1.93 26,893 32,683
2022-06-07 2022-06-03 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale -15,230 3,000 -83.54 6.05 -92,198 18,161
2022-06-07 2022-06-03 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise X 15,230 18,230 507.67 1.93 29,394 35,184
2022-05-18 2022-05-16 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale X -10,800 3,000 -78.26 7.42 -80,146 22,263
2022-05-03 2022-05-01 4 EWTX Edgewise Therapeutics, Inc.
Restricted Stock Units
A - Award 15,625 15,625
2022-01-25 2022-01-21 4 EWTX Edgewise Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -5,400 205,322 -2.56
2022-01-25 2022-01-21 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise 5,400 12,362 77.56 0.71 3,834 8,777
2021-12-30 2021-12-28 4 EWTX Edgewise Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -5,400 210,722 -2.50
2021-12-30 2021-12-28 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise 5,400 6,962 345.71 0.71 3,834 4,943
2021-08-19 2021-08-17 4 EWTX Edgewise Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 120,000 120,000
2017-04-06 2017-04-01 4/A ARRY ARRAY BIOPHARMA INC
Common Stock
F - Taxes -6,370 40,102 -13.71 8.94 -56,948 358,512
2017-04-04 2017-04-01 4 ARRY ARRAY BIOPHARMA INC
Restricted Stock Units
M - Exercise -6,718 20,157 -25.00
2017-04-04 2017-04-01 4 ARRY ARRAY BIOPHARMA INC
Common Stock
F - Taxes -4,408 42,064 -9.49 8.94 -39,408 376,052
2017-04-04 2017-04-01 4 ARRY ARRAY BIOPHARMA INC
Common Stock
M - Exercise 6,718 46,472 16.90
2016-12-29 2016-12-27 4 ARRY ARRAY BIOPHARMA INC
Stock Option (Right to Buy)
A - Award 131,250 131,250
2016-12-29 2016-12-27 4 ARRY ARRAY BIOPHARMA INC
Restricted Stock Units
A - Award 21,875 21,875
2016-09-14 2016-09-12 4 NVLS Nivalis Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 12,300 12,300
2016-04-05 2016-04-01 4 ARRY ARRAY BIOPHARMA INC
Stock Option (Right to Buy)
A - Award 161,250 161,250
2016-04-05 2016-04-01 4 ARRY ARRAY BIOPHARMA INC
Restricted Stock Units
A - Award 26,875 26,875
2016-04-05 2016-04-01 4 ARRY ARRAY BIOPHARMA INC
Common Stock
F - Taxes -2,505 39,754 -5.93 3.00 -7,515 119,262
2015-09-15 2015-09-11 4 NVLS Nivalis Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 7,650 7,650
2015-06-16 3 NVLS Nivalis Therapeutics, Inc.
Common Stock
4,326
2015-06-16 3 NVLS Nivalis Therapeutics, Inc.
Common Stock
4,326
2015-04-03 2015-04-01 4 ARRY ARRAY BIOPHARMA INC
Stock Option (Right to Buy)
A - Award 161,250 161,250
2015-04-03 2015-04-01 4 ARRY ARRAY BIOPHARMA INC
Common Stock
A - Award 26,875 42,259 174.69
2015-03-04 2015-03-01 4 ARRY ARRAY BIOPHARMA INC
Restricted Stock Units
M - Exercise -22,906 22,906 -50.00
2015-03-04 2015-03-01 4 ARRY ARRAY BIOPHARMA INC
Common Stock
F - Taxes -7,542 15,364 -32.93 7.96 -60,034 122,297
2015-03-04 2015-03-01 4 ARRY ARRAY BIOPHARMA INC
Common Stock
M - Exercise 22,906 22,906 7.96 182,332 182,332
2014-08-20 2014-08-18 4 ARRY ARRAY BIOPHARMA INC
Restricted Stock Units
A - Award 45,812 45,812
2014-04-03 2014-04-01 4 ARRY ARRAY BIOPHARMA INC
Stock Option (Right to Buy)
A - Award 125,000 125,000
2013-12-03 2013-11-29 4 ARRY ARRAY BIOPHARMA INC
Common Stock
S - Sale X -11,666 20 -99.83 5.79 -67,546 116
2013-11-15 2013-11-13 4 ARRY ARRAY BIOPHARMA INC
Common Stock
S - Sale X -200 11,686 -1.68 5.79 -1,158 67,662
2013-08-02 2013-08-02 4 ARRY ARRAY BIOPHARMA INC
Stock Option (Right to Buy)
M - Exercise X -30,000 30,000 -50.00
2013-08-02 2013-08-02 4 ARRY ARRAY BIOPHARMA INC
Stock Option (Right to Buy)
M - Exercise X -13,884 9,375 -59.69
2013-08-02 2013-08-02 4 ARRY ARRAY BIOPHARMA INC
Common Stock
S - Sale X -43,884 11,886 -78.69 7.03 -308,469 83,549
2013-08-02 2013-08-02 4 ARRY ARRAY BIOPHARMA INC
Common Stock
M - Exercise X 30,000 55,770 116.41 3.06 91,800 170,656
2013-08-02 2013-08-02 4 ARRY ARRAY BIOPHARMA INC
Common Stock
M - Exercise X 13,884 25,770 116.81 3.01 41,791 77,568
2013-08-02 2013-08-01 4 ARRY ARRAY BIOPHARMA INC
Stock Option (Right to Buy)
M - Exercise X -14,241 23,259 -37.98
2013-08-02 2013-08-01 4 ARRY ARRAY BIOPHARMA INC
Stock Option (Right to Buy)
M - Exercise X -12,500 12,500 -50.00
2013-08-02 2013-08-01 4 ARRY ARRAY BIOPHARMA INC
Common Stock
S - Sale X -31,500 11,886 -72.60 7.00 -220,635 83,253
2013-08-02 2013-08-01 4 ARRY ARRAY BIOPHARMA INC
Common Stock
M - Exercise X 14,241 43,386 48.86 3.01 42,865 130,592
2013-08-02 2013-08-01 4 ARRY ARRAY BIOPHARMA INC
Common Stock
M - Exercise X 12,500 29,145 75.10 2.74 34,250 79,857
2013-07-25 2013-07-25 4 ARRY ARRAY BIOPHARMA INC
Stock Option (Right to Buy)
M - Exercise -4,759 0 -100.00
2013-07-25 2013-07-25 4 ARRY ARRAY BIOPHARMA INC
Common Stock
M - Exercise 4,759 16,645 40.04 3.75 17,846 62,419
2013-07-25 2013-07-23 4 ARRY ARRAY BIOPHARMA INC
Stock Option (Right to Buy)
M - Exercise -5,000 25,000 -16.67
2013-07-25 2013-07-23 4 ARRY ARRAY BIOPHARMA INC
Common Stock
S - Sale X -5,000 11,886 -29.61 6.50 -32,500 77,259
2013-07-25 2013-07-23 4 ARRY ARRAY BIOPHARMA INC
Common Stock
M - Exercise X 5,000 16,886 42.07 2.74 13,700 46,268
2013-04-24 2013-04-23 4 ARRY ARRAY BIOPHARMA INC
Stock Option (Right to Buy)
M - Exercise -20,000 30,000 -40.00
2013-04-24 2013-04-23 4 ARRY ARRAY BIOPHARMA INC
Common Stock
D - Sale to Issuer X -20,000 11,886 -62.72 6.52 -130,400 77,497
2013-04-24 2013-04-23 4 ARRY ARRAY BIOPHARMA INC
Common Stock
M - Exercise X 20,000 31,886 168.27 2.74 54,800 87,368
2013-04-01 2013-03-28 4 ARRY ARRAY BIOPHARMA INC
Stock Option (Right to Buy)
A - Award 80,000 80,000
2012-10-09 2012-10-08 4 ARRY ARRAY BIOPHARMA INC
Common Stock
S - Sale X -2,357 0 -100.00 5.69 -13,401
2012-10-09 2012-10-08 4 ARRY ARRAY BIOPHARMA INC
Common Stock
S - Sale X -26,190 11,886 -68.78 5.69 -148,911 67,581
2012-10-05 2012-10-04 4 ARRY ARRAY BIOPHARMA INC
Common Stock
A - Award 11,886 38,076 45.38
2012-04-03 2012-03-30 4 ARRY ARRAY BIOPHARMA INC
Stock Option (Right to Buy)
A - Award 75,000 75,000
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券(例如股票期權)
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券(例如期權)
V
內部人士透過Form 4自願報告的一筆交易
J
其他(附有交易描述的腳註)